U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06885242) titled 'Efficacy and Safety of Cyclopentolate Microdrops for Cycloplegic Refraction in Children' on March 14.
Brief Summary: The purpose is to test the hypothesis that microdrop instillation of cyclopentolate 1% is non-inferior to standard of care, i.e., standard drop instillation of cyclopentolate 1%. Comparison, also, will be made to the subsequent adverse events.
Study Start Date: Sept. 06, 2024
Study Type: INTERVENTIONAL
Condition:
Cycloplegic Refraction
Intervention:
DEVICE: Microdrop instillation of cyclopentolate 1%
1 drop administered through the Nanodropper device adapted to the commercially available multi-dose dropper bot...